The potential of coenzyme Q 10 (NSC-140865) in cancer treatment.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002642:Chick Embryo; D006224:Cricetinae; D000882:Haplorhini; D006801:Humans; D050356:Lipid Metabolism; D008661:Metabolism, Inborn Errors / Q000378:metabolism; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D010545:Peroxides / Q000378:metabolism; D010649:Phenylalanine / Q000172:deficiency; D011817:Rabbits; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D013385:Succinate Dehydrogenase / Q000378:metabolism; D014422:Turkeys; D014443:Tyrosine / Q000172:deficiency; D014451:Ubiquinone / Q000172:deficiency / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D010545:Peroxides; D014451:Ubiquinone; D014443:Tyrosine; D010649:Phenylalanine; D013385:Succinate Dehydrogenase